Trim Biome GLP-1 is designed to complement a healthy diet and exercise routine by supporting the body's natural fat metabolism processes.*
Cell Proliferation and Neoplastic Concerns Theoretically, any growth factor that promotes cell proliferation raises theoretical concerns about uncontrolled growth and neoplastic transformation
It belongs to a class of medicines called GLP-1 receptor agonists drugs that work by mimicking a gut hormone your body makes naturally
The peptide acts as a signalling molecule that communicates with cells, telling them to repair, regenerate, and produce essential proteins
Modulating the microbiota/SCFA/bile acid-signaling to impact metabolism and inflammatory processes via GLP-1 and other mechanisms, therefore, represents a new strategy for the treatment of several chronic diseases
2024 JAMA Ophthalmology Study Findings The landmark Harvard Medical School study published in JAMA Ophthalmology in July 2024 provided the first rigorous scientific evidence linking semaglutide to elevated NAION risk analyzing 16,827 patients at Massachusetts Eye and Ear and revealing alarming risk multipliers that prompted global regulatory scrutiny
